Bank of America Securities Sticks to Its Sell Rating for Fresenius Medical Care (FMS)
TipRanksApr 19 09:55 ET
Research Alert: CFRA Keeps Sell Opinion On Adss Of Fresenius Medical Care
MT NewswiresFeb 21 07:30 ET
Fresenius Medical Care Analyst Ratings
BenzingaNov 24, 2023 05:16 ET
Analysts Conflicted on These Healthcare Names: Fresenius Medical Care (FMS), Solid Biosciences (SLDB) and Merck & Company (MRK)
TipRanksNov 20, 2023 02:10 ET
Research Alert: CFRA Keeps Sell Opinion On Adss Of Fresenius Medical Care
MT NewswiresNov 3, 2023 03:35 ET
Research Alert: CFRA Keeps Sell Opinion On Adss Of Fresenius Medical Care
MT NewswiresOct 12, 2023 01:05 ET
Truist Securities Maintains Hold on Fresenius Medical Care, Lowers Price Target to $24
BenzingaOct 11, 2023 15:55 ET
Fresenius Medical Care Analyst Ratings
BenzingaOct 11, 2023 15:54 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Fresenius Medical Care AG & Co. KGaA (GB:0H9X), Shop Apotheke Europe NV (GB:0RJT) and Scholar Rock Holding (SRRK)
TipRanksAug 3, 2023 05:04 ET
Analysts Offer Insights on Healthcare Companies: Fresenius Medical Care AG & Co. KGaA (GB:0H9X), Ansell (OtherANSLF) and COSMO Pharmaceuticals N.V. (GB:0RGI)
TipRanksJul 21, 2023 05:06 ET
Fresenius Medical Care Analyst Ratings
BenzingaJul 13, 2023 12:47 ET
Truist Securities Adjusts Fresenius Medical Care Price Target to $28 From $26, Maintains Hold Rating
MT NewswiresJul 13, 2023 11:10 ET
Truist Securities Adjusts Price Target on Fresenius Medical Care to $26 From $24, Keeps Hold Rating
MT NewswiresMay 10, 2023 10:59 ET
Truist Securities Maintains Hold on Fresenius Medical Care, Raises Price Target to $26
BenzingaMay 10, 2023 09:20 ET
Truist Securities Adjusts Price Target on Fresenius Medical Care to $24 From $22, Maintains Hold Rating
MT NewswiresApr 13, 2023 10:28 ET
Credit Suisse Boosts Price Target on Fresenius Medical Care to EUR35 From EUR32, Keeps Neutral Rating
MT NewswiresMar 14, 2023 07:48 ET
Research Alert: CFRA Keeps Sell Opinion On Adss Of Fresenius Medical Care
MT NewswiresFeb 24, 2023 00:12 ET
Truist Securities Maintains Hold on Fresenius Medical Care, Raises Price Target to $22
BenzingaFeb 23, 2023 10:37 ET
Credit Suisse Cuts Price Target on Fresenius Medical Care to EUR32 From EUR37, Citing Margin Pressure, Higher Financing Costs; Neutral Rating Kept
MT NewswiresNov 9, 2022 08:25 ET
Research Alert: CFRA Lowers Opinion On Adss Of Fresenius Medical Care To Sell From Hold
MT NewswiresNov 1, 2022 03:26 ET
No Data
No Data